Fidia Pharma Group launches brand new Hymovis website

Let's move, with Hymovis!

We are pleased to announce the release of our new www.hymovis.net website, designed with a user-friendly navigation, and updated with the latest information on the product.

Our objective is to provide our international visitors with an easier way to learn about Hymovis and to browse information about osteoarthritis.

We will be updating our content with helpful information and articles, and wish to establish this portal as a source of information for those who visit our site.


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine